尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Smith W Bradford, 首席财务官. Insider active across 2 companies, notably Homology Medicines, Inc.. In total, 4 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €5k. Activity tracked since 9 January 2023. The latest transaction was filed on 14 May 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
W. Bradford Smith is the CFO & Treasurer at Homology Medicines, Inc. and Lyra Therapeutics, Inc. He oversees the financial operations of both companies, including budgeting and financial reporting. With significant experience in finance, Smith plays a key role in managing financial resources and growth strategy.